Literature DB >> 3593584

Alveolo-capillary membrane in primary pulmonary hypertension.

S Villaschi, G G Pietra.   

Abstract

This study was undertaken to detect diagnostic ultrastructural changes in the alveolar walls in biopsies of patients with primary pulmonary hypertension (PPH). Open lung biopsies from 8 patients referred to the Hospital of the University of Pennsylvania were available for study. By light microscopy 4 patients were diagnosed as having plexogenic pulmonary arteriopathy, 2 thromboembolic arteriopathy and 2 veno-occlusive (PVOD) disease. In 4 patients the diagnosis of PPH was further confirmed at autopsy. Changes were observed in the basement membrane of the alveolar capillaries in 6 of the patients. These consisted in marked thickening and duplication of the basement membrane of alveolar capillaries in the 4 patients with the plexogenic form of pulmonary hypertension. Patients with PVOD instead showed uniform thickening of the basement membrane. No changes were detected in the 2 biopsies of patients with the thromboembolic form of PPH. We conclude that ultrastructural studies contribute significantly to the precise characterization of pathologic changes in the lungs of patients with PPH.

Entities:  

Mesh:

Year:  1986        PMID: 3593584

Source DB:  PubMed          Journal:  Appl Pathol        ISSN: 0252-1172


  3 in total

1.  Deciphering the nitric oxide to carbon monoxide lung transfer ratio: physiological implications.

Authors:  Stéphane N Glénet; Claire De Bisschop; Frederic Vargas; Hervé J P Guénard
Journal:  J Physiol       Date:  2007-05-10       Impact factor: 5.182

2.  PHD2 deletion in endothelial or arterial smooth muscle cells reveals vascular cell type-specific responses in pulmonary hypertension and fibrosis.

Authors:  Harri Elamaa; Mika Kaakinen; Marjut Nätynki; Zoltan Szabo; Veli-Pekka Ronkainen; Ville Äijälä; Joni M Mäki; Risto Kerkelä; Johanna Myllyharju; Lauri Eklund
Journal:  Angiogenesis       Date:  2022-01-08       Impact factor: 10.658

3.  Phenotypic Characterization of EIF2AK4 Mutation Carriers in a Large Cohort of Patients Diagnosed Clinically With Pulmonary Arterial Hypertension.

Authors:  Charaka Hadinnapola; Marta Bleda; Matthias Haimel; Nicholas Screaton; Andrew Swift; Peter Dorfmüller; Stephen D Preston; Mark Southwood; Jules Hernandez-Sanchez; Jennifer Martin; Carmen Treacy; Katherine Yates; Harm Bogaard; Colin Church; Gerry Coghlan; Robin Condliffe; Paul A Corris; Simon Gibbs; Barbara Girerd; Simon Holden; Marc Humbert; David G Kiely; Allan Lawrie; Rajiv Machado; Robert MacKenzie Ross; Shahin Moledina; David Montani; Michael Newnham; Andrew Peacock; Joanna Pepke-Zaba; Paula Rayner-Matthews; Olga Shamardina; Florent Soubrier; Laura Southgate; Jay Suntharalingam; Mark Toshner; Richard Trembath; Anton Vonk Noordegraaf; Martin R Wilkins; Stephen J Wort; John Wharton; Stefan Gräf; Nicholas W Morrell
Journal:  Circulation       Date:  2017-09-28       Impact factor: 29.690

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.